NCT07425730 Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
| NCT ID | NCT07425730 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai Jiao Tong University School of Medicine |
| Condition | Systemic Lupus Erythematosus (SLE) |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2026-02-01 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate biomarkers to identify pediatric SR-SLE patients by non-invasive echocardiographic techniques.
Eligibility Criteria
Inclusion Criteria: * fulfill the American College of Rheumatology (ACR) criteria * disease onset at ages before 18 years Exclusion Criteria: * patients with a history of concomitant malignancy * patients with active bacterial, viral, fungal, mycobacterial infection
Contact & Investigator
Bao
PRINCIPAL INVESTIGATOR
Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine
Frequently Asked Questions
Who can join the NCT07425730 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 17 Years, studying Systemic Lupus Erythematosus (SLE). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07425730 currently recruiting?
Yes, NCT07425730 is actively recruiting participants. Visit ClinicalTrials.gov or contact Shanghai Jiao Tong University School of Medicine to inquire about joining.
Where is the NCT07425730 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07425730 clinical trial?
NCT07425730 is sponsored by Shanghai Jiao Tong University School of Medicine. The principal investigator is Bao at Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.